Chemoprevention of mammary carcinoma by LGD1069 (Targretin): An RXR- selective ligand

Cancer Research

Volumn 56, Issue 24, 1996, Pages 5566-5570

  Gottardis, Marco M ^a   Bischoff, Eric D ^a   Shirley, Michael A ^a   Wagoner, Murriel A ^a   Lamph, William W ^a   Heyman, Richard A ^a  

^a LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEXAROTENE; ESTRADIOL; LIGAND; METHYLNITROSOUREA; PROGESTERONE; PROLACTIN; RETINOID X RECEPTOR; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BREAST CARCINOMA; CANCER INCIDENCE; CANCER PREVENTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG RECEPTOR BINDING; FEMALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; UTERUS WEIGHT;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TETRAHYDRONAPHTHALENES; TRANSCRIPTION FACTORS; UTERUS;

EID: 0029731340     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Anzano, M A , Byers, S W., Smith, J. M., Peer, C. W., Mullen, L. T., Brown, C C., Roberts, A. B., and Sporn, M. B. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res., 54: 4614-4617, 1994.
2. Gottardis, M. M., and Jordan, V. C Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res., 47: 4020-4024, 1987
3. Jordan, V. C Studies on the estrogen receptor in breast cancer-20 years as a target for the treatment and prevention of cancer. Breast Cancer Res Treat, 36: 267-285, 1995.
4. Jordan, V. C. Alternate antiestrogens and approaches to the prevention of breast cancer J. Cell Biochem , 22 (Suppl.): 51-57, 1995.
5. Moon, R. C., Mehta, R G , and Rao, K. V. N. Retinoids and cancer in experimental animals. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, pp. 573-595. New York: Raven Press, 1994.
6. Lippman, S. M., Benner, S E , and Hong, W. K Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res., 54: 2025S-2028S, 1994.
7. Costa, A , Formelli, F., Chiesa, F., Decensi, A , De Palo, G., and Veronesi, U. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res , 54 2032S-2037S, 1994.
8. Costa, A., De Palo, G., Decensi, A , Formelli, F., Chiesa, F , Nava, M., Camerini, T., Marubini, E., and Veronesi, U. Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide. Ann. NY Acad. Sci., 768: 148-162, 1995.
9. Boehm, M F , Zhang, L., Badea, B A., White, S K., Mais, D E., Berger, E., Suto, C. M., Goldman, M. E., and Heyman, R. A. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J Med. Chem., 37: 2930-2941, 1994
10. Nadzan, A. M. Retinoids for the treatment of oncology diseases. In: J. A Bristol (ed.), Annual Reports in Medicinal Chemistry, Vol 30, pp 119-128. San Diego: Academic Press, Inc., 1995.
11. Nagy, L , Thomazy, V. A , Shipley, G. L , Fesus, L , Lamph, W , Heyman, R A., Chandraratna, R A., and Davies, P. J. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol., 15: 3540-3551, 1995.
12. Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A , Stein, R. B., Eichele, G., Evans, R. M , and Thaller, C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 68: 397-406, 1992
13. Allegretto, E. A , McClurg, M R., Lazarchik, S. B , Clemm, D L., Kerner, S A., Elgort, M. G , Boehm, M. F., White, S. K., Pike, J. W., and Heyman, R. A. Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. Correlation with hormone binding and effects of metabolism [published erratum appears in J. Biol. Chem. 269: 7834, 1994]. J. Biol. Chem , 268: 26625-26633, 1993.
14. Dawson, M. I., Jong, L , Hobbs, P. D , Cameron, J. F., Chao, W R , Pfahl, M , Lee, M. O , and Shroot, B. Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J Med. Chem , 38: 3368-3383, 1995.
15. Welsch, C. W. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res , 45: 3415-3443, 1985.
16. Rizvi, N. A , Marshall, J. L , Loewen, G R , Ulm, E. H., Gill, G M , Truglia, J. A., Ness, E., Clarke, R., and Hawkins, M. J. A phase I study of Targretin, an RXR-selective retinoid agonist. Proc. Am Assoc. Cancer Res., 37: 165, 1996.
17. Miller, V A., Benedetti, F. M., Rigis, J. R., Verret, A. L., Pfister, D. G., Straus, D., Kris, M. G., Crisp, M R., Heyman, R., Loewen, G. R , Truglia, J. A., and Warrell, R. P., Jr. Initial clinical trial of the selective retinoid X receptor ligand, LGD1069 (Targretin) J. Clin. Oncol , in press, 1996
18. Mangelsdorf, D J , Umesono, K , and Evans, R M. The retinoid receptors. In: M. B. Sporn, A B. Roberts, and D. S Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, pp 319-349 New York: Raven Press, 1994.
19. Mangelsdorf, D J., and Evans, R M The RXR heterodimers and orphan receptors Cell, 83: 841-850, 1995.
20. Furr, B. J , and Jordan, V. C. The pharmacology and clinical uses of tamoxifen Pharmacol Ther , 25: 127-205, 1984.
21. Boettger-Tong, H L , and Stancel, G M. Retinoic acid inhibits estrogen-induced uterine stromal and myometrial cell proliferation. Endocrinology, 136: 2975-2983, 1995.
22. Gottardis, M M , Lamph, W. W , Shalinsky, D. R., Wellstein, A., and Heyman, R. A. The efficacy of 9-cis retinoic acid in experimental models of cancer. Breast Cancer Res. Treat , 38: 85-96, 1996.
23. Keller, H , Givel, F., Perroud, M., and Wahli, W. Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol Endocnnol , 9 794-804, 1995
24. Ratko, T A., Detrisac, C. J., Dinger, N. M , Thomas, C. F , Kelloff, G. J., and Moon, R C Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res , 49: 4472-4476, 1989